Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel actions of sclerostin on bone
Gill Holdsworth, Scott J. Roberts, Hua Zhu Ke
Journal of Molecular Endocrinology (2018) Vol. 62, Iss. 2, pp. R167-R185
Open Access | Times Cited: 87

Showing 1-25 of 87 citing articles:

Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Guideline Update
Dolores Shoback, Clifford J. Rosen, Dennis M. Black, et al.
The Journal of Clinical Endocrinology & Metabolism (2020) Vol. 105, Iss. 3, pp. 587-594
Open Access | Times Cited: 311
Update on Osteoporosis Screening and Management
Anika K. Anam, Karl Insogna
Medical Clinics of North America (2021) Vol. 105, Iss. 6, pp. 1117-1134
Closed Access | Times Cited: 163
Current advances in regulation of bone homeostasis
Md. Abdul Alim Al‐Bari, Abdullah Al Mamun
FASEB BioAdvances (2020) Vol. 2, Iss. 11, pp. 668-679
Open Access | Times Cited: 103
Bone and Muscle Crosstalk in Aging
Chen He, Wenzhen He, Jing Hou, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 92
Sclerostin and Osteocalcin: Candidate Bone-Produced Hormones
Jialiang S. Wang, Courtney M. Mazur, Marc N. Wein
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 84
Therapeutic aptamer targeting sclerostin loop3 for promoting bone formation without increasing cardiovascular risk in osteogenesis imperfecta mice
Luyao Wang, Yuanyuan Yu, Shuaijian Ni, et al.
Theranostics (2022) Vol. 12, Iss. 13, pp. 5645-5674
Open Access | Times Cited: 62
Osteocytes and Estrogen Deficiency
Laoise M. McNamara
Current Osteoporosis Reports (2021) Vol. 19, Iss. 6, pp. 592-603
Closed Access | Times Cited: 57
Romosozumab in osteoporosis: yesterday, today and tomorrow
Dong Wu, Lei Li, Zhun Wen, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 27
Osteoporosis management-current and future perspectives – A systemic review
Rajamohanan Jalaja Anish, Aswathy Nair
Journal of Orthopaedics (2024) Vol. 53, pp. 101-113
Closed Access | Times Cited: 15
Integrins in Osteocyte Biology and Mechanotransduction
Ivor P. Geoghegan, David A. Hoey, Laoise M. McNamara
Current Osteoporosis Reports (2019) Vol. 17, Iss. 4, pp. 195-206
Closed Access | Times Cited: 73
Sclerostin: from bench to bedside
Sakae Tanaka, Toshio Matsumoto
Journal of Bone and Mineral Metabolism (2020) Vol. 39, Iss. 3, pp. 332-340
Closed Access | Times Cited: 67
Muscle-Bone Crosstalk in the Masticatory System: From Biomechanical to Molecular Interactions
Sonja Buvinic, Julián Balanta‐Melo, Kornelius Kupczik, et al.
Frontiers in Endocrinology (2021) Vol. 11
Open Access | Times Cited: 52
MicroRNAs Modulate Signaling Pathways in Osteogenic Differentiation of Mesenchymal Stem Cells
Chiara Mazziotta, Carmen Lanzillotti, Maria Rosa Iaquinta, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 5, pp. 2362-2362
Open Access | Times Cited: 49
A cholinergic neuroskeletal interface promotes bone formation during postnatal growth and exercise
Stephen Gadomski, Claire Fielding, Andrés García‐García, et al.
Cell stem cell (2022) Vol. 29, Iss. 4, pp. 528-544.e9
Open Access | Times Cited: 35
Drug discovery of sclerostin inhibitors
Sifan Yu, Dijie Li, Ning Zhang, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 5, pp. 2150-2170
Open Access | Times Cited: 34
WNT-modulating gene silencers as a gene therapy for osteoporosis, bone fracture, and critical-sized bone defects
Won-Taek Oh, Yeon‐Suk Yang, Jun Xie, et al.
Molecular Therapy (2022) Vol. 31, Iss. 2, pp. 435-453
Open Access | Times Cited: 32
Pharmaceutical treatment of bone loss: From animal models and drug development to future treatment strategies
Mikkel Bo Brent
Pharmacology & Therapeutics (2023) Vol. 244, pp. 108383-108383
Open Access | Times Cited: 20
Nonclinical cardiovascular safety evaluation of romosozumab, an inhibitor of sclerostin for the treatment of osteoporosis in postmenopausal women at high risk of fracture
James R. Turk, Aimée M. Deaton, Jun Yin, et al.
Regulatory Toxicology and Pharmacology (2020) Vol. 115, pp. 104697-104697
Open Access | Times Cited: 40
Etiological Mechanisms and Genetic/Biological Modulation Related to PTH1R in Primary Failure of Tooth Eruption
Xiao-xia Li, Man-ting Wang, Zhifang Wu, et al.
Calcified Tissue International (2024) Vol. 115, Iss. 2, pp. 101-116
Closed Access | Times Cited: 4
A systematic study of the effect of measurement parameters on determination of osteocyte lacunar properties using laboratory X-ray micro-computed tomography
Maja Østergaard, Nina Kølln Wittig, Henrik Birkedal
Bone (2025), pp. 117391-117391
Open Access
Porcupine inhibition is a promising pharmacological treatment for severe sclerosteosis pathologies
T. Dreyer, Jacob A.C. Keen, Leah Wells, et al.
Bone Research (2025) Vol. 13, Iss. 1
Open Access
The Bone Marrow Microenvironment in B-Cell Development and Malignancy
Anastasia Hughes, Vincent Kuek, Rishi S. Kotecha, et al.
Cancers (2022) Vol. 14, Iss. 9, pp. 2089-2089
Open Access | Times Cited: 17
Meta-analysis of the effects of denosumab and romosozumab on bone mineral density and turnover markers in patients with osteoporosis
Mingwei Hu, Yifan Zhang, Jianjun Guo, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 9
Evaluating the correlation of sclerostin levels with obesity and type 2 diabetes in a multiethnic population living in Kuwait
Tahani Alramah, Preethi Cherian, Irina Al‐Khairi, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 3
A bone adhesive enhances osteoporotic fracture repair by regulating bone homeostasis
Shenghui Su, Jiajun Xie, Jian Gao, et al.
NPG Asia Materials (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top